Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

miRNAs and Target Genes in Breast Cancer MetastasisMolecular Targeted Therapy for Brain Metastatic Breast Cancers: Current Updates

miRNAs and Target Genes in Breast Cancer Metastasis: Molecular Targeted Therapy for Brain... [Metastatic breast cancers are difficult to manage, and brain metastatic breast cancers are particularly lethal with poor overall survival and outcomes. Our understanding of factors that facilitate brain metastasis of breast cancers is very poor. However, a number of studies in the last few years have focused on brain metastatic breast cancers; a number of therapeutic targets have been tested, and few therapeutic regimes have also been evaluated in phase I/II settings. We discuss here some of the most recent developments in the field. We will limit our discussion to the reports from past one year only to make this article most up-to-date with no repetition of information that has already been reviewed in the available literature.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

miRNAs and Target Genes in Breast Cancer MetastasisMolecular Targeted Therapy for Brain Metastatic Breast Cancers: Current Updates

Loading next page...
 
/lp/springer-journals/mirnas-and-target-genes-in-breast-cancer-metastasis-molecular-targeted-psrzYt8lx0

References (57)

Publisher
Springer International Publishing
Copyright
© Springer International Publishing Switzerland 2014
ISBN
978-3-319-08161-8
Pages
65 –75
DOI
10.1007/978-3-319-08162-5_6
Publisher site
See Chapter on Publisher Site

Abstract

[Metastatic breast cancers are difficult to manage, and brain metastatic breast cancers are particularly lethal with poor overall survival and outcomes. Our understanding of factors that facilitate brain metastasis of breast cancers is very poor. However, a number of studies in the last few years have focused on brain metastatic breast cancers; a number of therapeutic targets have been tested, and few therapeutic regimes have also been evaluated in phase I/II settings. We discuss here some of the most recent developments in the field. We will limit our discussion to the reports from past one year only to make this article most up-to-date with no repetition of information that has already been reviewed in the available literature.]

Published: Sep 6, 2014

Keywords: Breast cancer; Brain metastasis; Blood–brain barrier; Estrogen receptor-negative breast cancer; HER2-positive breast cancer

There are no references for this article.